Cancer Research

Bavarian Nordic- Strengthens Commercial Focus; Pipeline Update

Contract No. HHSO100200700034C. Contact: Elizabeth Dempsey Becker, Bavarian Nordic, Inc., +1-202-536-1576 ...

Article - Anna Ohlden - Sep 20 2007 - 10:53am

Protherics Licenses Its CoVaccine HT Adjuvant To Nobilon For Influenza Vaccine Indications

Pursuant to the U.S. Private Securities Litigation Reform Act 1995. For more information, please contact ...

Article - Anna Ohlden - Sep 26 2007 - 2:06am

Bavarian Nordic Receives US$50 Million Advance Payment From HHS For Fulfilling Contract Milestones

reports, if any, which we incorporate by reference. Contact: Elizabeth Dempsey Becker, Bavarian Nordic, ...

Article - Anna Ohlden - Oct 9 2007 - 10:12am

No 'Love, Actually' For People With RA- Research Shows The Real Price Of Rheumatoid Arthritis

Andrew Östör, please contact: Red Door Communications, Sarah Aldridge, Telephone: +44(0)20-8392-8040, ...

Article - Anna Ohlden - Oct 11 2007 - 7:02pm

Astex Drug Candidates To Be Featured At The 2007 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therape

http://www.astex-therapeutics.com Web: http://www.astex-therapeutics.com Contacts: Astex Therapeutics Limited, Jeremy Carmichael, ...

Article - Anna Ohlden - Oct 18 2007 - 11:23am

Oncolytics Biotech Inc. Collaborators To Present Positive Interim Results Of U.K. Phase Ia/Ib Combination REOLYSIN(R) And Radiat

largest comprehensive cancer centre in Europe. This relationship enables close daily contact between ...

Article - Anna Ohlden - Oct 24 2007 - 1:10am

DARA BioSciences, Inc. Announces New Board Chairman

information please contact the Company at +1-919-872-5578 or visit our web site at www.darabiosciences.com. ...

Article - Anna Ohlden - Oct 25 2007 - 6:47am

PetScreen Supports Morris Animal Foundation Canine Cancer Campaign; Co-Sponsors Two Canine Cancer Studies

+1-800-243-2345, or visit http://www.MorrisAnimalFoundation.org. Media Contact: Michael Burke ...

Article - Anna Ohlden - Nov 1 2007 - 12:26pm

Xenomics Announces Issuance Of A US Patent That Covers Use Of Transrenal Nucleic Acid Technology For Infectious Disease Diagnost

personnel, and the need for additional financing. CONTACT: Samuil Umansky Xenomics, Inc. +1-732-438-8290 ext. ...

Article - Anna Ohlden - Nov 14 2007 - 1:03pm

Industry Successes Celebrated At Scrip Awards 2007

For editorial information contact: Alex Shimmings, Editor Tel: +44(0)20-7017-6954 Email: ...

Article - Anna Ohlden - Dec 5 2007 - 12:30pm